- Grants since 2016
- 239
- Awarded, last 5 years (where amounts are published)
- 34M
- Funded works, last 5 years
- 2 662
- Funded works, all time
- 7 142
Grants
2026 · research
Developing a new antibody-based immunotherapy that activates the immune system to generate stronger and longer-lasting anti-cancer immunity in breast cancer
Jeffrey Ravetch · Rockefeller University
2026 · research
Developing engineered immune cell therapy to improve treatment effectiveness in breast cancer
Ellen Puré · University of Pennsylvania
2026 · research
Understanding how breast cancer treatments can unintentionally damage the heart
Zhen Guo
2026 · research
Uncovering how breast cancer stem cells evade the immune system to survive treatment and drive recurrence in triple-negative breast cancer
Evelyn Jiagge · Henry Ford Health
2026 · research
Providing a large, resource rich database to support research on long-term survivorship in postmenopausal women with breast cancer
Garnet L. Anderson · Fred Hutch Cancer Center
2026 · research
Investigating whether a common genetic variant contributes to racial disparities in cancer treatment and outcomes
Lauren Merz · University of Michigan
2026 · research
Investigating whether naturally occurring autoantibodies help protect certain high-risk individuals from developing cancer, with a focus on hereditary breast cancer
Paul Bastard · Hôpital Necker-Enfants Malades
2026 · research
Testing drug combinations to make immunotherapy more effective for ER-positive, HER2-negative metastatic breast cancer
Sherry Shen · Memorial Sloan Kettering Cancer Center
2026 · research
Using AI tools to accelerate the discovery of biomarkers and treatment insights in breast cancer
Eliezer Van Allen · Dana-Farber Cancer Institute
2026 · research
Testing low-dose radiation as a targeted treatment for side effects caused by immunotherapy
Chidinma Anakwenze · The University of Texas MD Anderson Cancer Center
2026 · research
Uncovering how breast cancer cells hijack sensory nerves to fuel tumor growth and metastasis, with the goal of developing new anti-metastatic therapies
Veena Padmanaban · Johns Hopkins University
2026 · research
Determining how much supervised exercise support is needed to improve health outcomes for breast cancer patients in order to make exercise a routine part of breast cancer care
Kathryn Schmitz · University of Pittsburgh
2026 · research
Determining whether some patients with HER2-positive metastatic breast cancer can safely stop therapy
Stefania Morganti · Dana-Farber Cancer Institute
2026 · research
Developing a combination therapy that targets both cancer cells and the immune cells that protect them to improve treatment response in triple-negative breast cancer
Qiwei Wang · University of Virginia
2026 · research
Using artificial intelligence to better classify invasive lobular carcinoma and predict which patients are at highest risk of relapse
Lounes Djerroudi · Institut Curie
2026 · research
Developing a dual-targeting antibody-based therapy for HER2-positive metastatic breast cancer
Ansel Nalin · The University of Texas MD Anderson Cancer Center
2026 · research
Targeting immune cells to prevent breast cancer from spreading to the brain
Briana To · The Ohio State University
2026 · research
Using advanced genetic sequencing to improve detection and interpretation of inherited breast cancer risk
Sulin Wu · University of Chicago
2026 · research
Developing a blood test to identify which patients with metastatic breast cancer are still benefiting from CDK4/6 inhibitor therapy
Tyler Kristoff · Emory University
2026 · research
Investigating whether naturally occurring autoantibodies help protect certain high-risk individuals from developing cancer, with a focus on hereditary breast cancer
Karl Smith-Byrne · University of Oxford
2026 · research
Investigating how the gut microbiome influences side effects from treatment
Maeve Hennessy · University of Chicago
2026 · research
Improving blood tests to detect breast cancer at its earliest stages in people with inherited cancer syndromes
Trevor Pugh · University of Toronto
2026 · research
Personalizing treatment for older women with low-risk breast cancer
Icro Meattini · University of Florence
2026 · research
Engineering next-generation antibody-drug conjugates to more precisely target and treat metastatic triple-negative breast cancer
Hung Nguyen · Dartmouth College
2026 · research
Developing a blood-based test to predict treatment resistance in estrogen receptor-positive metastatic breast cancer, with a focus on the understudied lobular subtype
Marina Sharifi · University of Wisconsin–Madison
2026–2028 · award
Molecular drivers of invasive lobular cancer
Adrian Lee · University of Pittsburgh
2026–2028 · award
Molecular and Clinical Characterization of Germline BRCA, PALB2, and TP53–Altered ER+ Breast Cancers: Implications for Biology and Therapy
Judy Garber · Dana-Farber Cancer Institute
2026–2027 · award
A phase 2 study of peri-operative immune therapy and cryoablation versus standard perioperative care in women with hormone receptor-negative, HER2-negative early stage/resectable breast cancer.
Heather Mcarthur · The University Of Texas Southwestern Medical Center (ut Southwestern)
2026–2027 · award
Engineered synthetic cells for breast cancer therapy
Adrian Harris · University of Oxford
2026–2028 · award
Project Title: Targeting Immunological and Physiological Triggers of Early-Onset Breast Cancer in Young Women
Camila Dos Santos · St. Jude Children's Research Hospital
2026–2028 · award
Development and implementation testing of a breast cancer–specific clinical trials communication framework
Carmen Guerra · University of Pennsylvania
2026–2028 · award
Adipocyte Directed Vaccination to Reduce the Risk of Breast Cancer
Mary Disis · University of Washington
2026–2027 · award
The Healthy Living Program: A novel precision-lifestyle and survivorship care model
Neil Iyengar · Winship Cancer Institute
2026–2028 · award
Annual or Biennial Screening Contrast-Enhanced Mammography in Women with Personal History of Breast Cancer
Wendie Berg · University of Pittsburgh
2026–2027 · award
BELLADONNA-2
Jakob Nikolas Kather · Heidelberg University
2026–2027 · award
Immune sensing of DNA damage in breast cancer
Gaorav Gupta · University of North Carolina at Chapel Hill
2026–2027 · award
Inducing Immunity to Treatment-Resistant Breast Cancer Stem Cells
Keith Knutson · Mayo Clinic in Florida
2026–2028 · award
Preclinical and clinical studies of breast cancer prevention with transdermal anti- progesterone agents
Seema Khan · Northwestern University
2026–2027 · award
Developing inhibitors of xCT
Alan Ashworth · Regent University
2026–2028 · award
Physical Activity, Diet, Weight and Breast Cancer Survivorship.
Melinda Irwin · Yale University